Literature DB >> 6404659

Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization.

L L Veeck, J W Wortham, J Witmyer, B A Sandow, A A Acosta, J E Garcia, G S Jones, H W Jones.   

Abstract

Oocytes of varying stages of maturity were aspirated from follicles primed with either human menopausal gonadotropin (hMG) and human chorionic gonadotropin (hCG) or a combination of follicle-stimulating hormone (FSH), hMG and hCG. Of the aspirated oocytes from 44 cycles, 74 were considered to be immature by virtue of morphologic characteristics of the oocytes and the degree of intercellular expansion of the associated cumular and membrana granulosa cells. After incubation periods of 22 to 35 hours in a Ham's F-10-based culture medium, these immature oocytes were inseminated with sperm donated by the patient's husband. Ultimately, 44 conceptuses were transferred to the respective uteri of 30 patients. Eight pregnancies were established as a result of these 30 transfers, two of which resulted from the transfer of only developed immature oocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6404659     DOI: 10.1016/s0015-0282(16)47052-4

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  75 in total

1.  Are cumulus cells necessary for the spontaneous maturation of germinal vesicle-stage oocytes to metaphase II.

Authors:  M Häberle; P Scheurer; K Lauerer; M Fischer; M K Hohl
Journal:  J Assist Reprod Genet       Date:  1999-07       Impact factor: 3.412

2.  Human embryos derived from in vitro and in vivo matured oocytes: analysis for chromosomal abnormalities and nuclear morphology.

Authors:  C DeScisciolo; D L Wright; J F Mayer; W Gibbons; S J Muasher; S E Lanzendorf
Journal:  J Assist Reprod Genet       Date:  2000-05       Impact factor: 3.412

3.  The effect of preincubation period of oocytes on nuclear maturity, fertilization rate, embryo quality, and pregnancy outcome in IVF and ICSI.

Authors:  Jason Yen-Ping Ho; Ming-Jer Chen; Yu-Chiao Yi; Hwa-Fen Guu; Esther Shih-Chu Ho
Journal:  J Assist Reprod Genet       Date:  2003-09       Impact factor: 3.412

4.  Hormonal stimulation for in vitro fertilization: a comparison of fertilization rates and cytogenetic findings in unfertilized oocytes.

Authors:  P De Sutter; M Dhont; D Vandekerckhove
Journal:  J Assist Reprod Genet       Date:  1992-06       Impact factor: 3.412

5.  Improved pregnancy outcome with gonadotropin releasing hormone agonist (GnRH-a) stimulation is due to the improvement in oocyte quantity rather than quality.

Authors:  H C Liu; Y M Lai; O Davis; A S Berkeley; M Graf; J Grifo; J Cohen; Z Rosenwaks
Journal:  J Assist Reprod Genet       Date:  1992-08       Impact factor: 3.412

6.  The genetic risks of in vitro fertilization techniques: the use of an animal model.

Authors:  J Santaló; J Badenas; J M Calafell; V Català; S Munné; J Egozcue; A M Estop
Journal:  J Assist Reprod Genet       Date:  1992-10       Impact factor: 3.412

7.  Ovarian stimulation for in vitro fertilization in low-responder patients using pulsatile intravenous follicle stimulating hormone.

Authors:  M C Edelstein; R G Brzyski; G S Jones; S J Muasher
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-10

8.  High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization.

Authors:  G E Hofmann; J P Toner; S J Muasher; G S Jones
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-10

9.  Impact of leuprolide acetate on the response to follicular stimulation for in vitro fertilization in patients with normal basal gonadotropin levels.

Authors:  R G Brzyski; G S Jones; S Oehninger; A A Acosta; C H Kruithoff; S J Muasher
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-10

10.  Use of failed-fertilized oocytes for diagnostic zona binding purposes after sperm binding improvement with a modified medium.

Authors:  R Henkel; C Müller; T Stalf; W B Schill; D R Franken
Journal:  J Assist Reprod Genet       Date:  1999-01       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.